Dear Doctor - Participate in the Survey on psoriatic arthritis " A new survey has found that psoriatic arthritis can have a significant impact on patients' quality of life. The study, which was conducted by the National Psoriasis Foundation (NPF), surveyed more than 3,500 people with psoriatic arthritis and found that the condition can severely affect patients physically, emotionally, and socially.The NPF survey found that psoriatic arthritis can cause pain, fatigue, stiffness, joint damage, and disability. The condition can also lead to depression and anxiety. In addition, the survey found that people with psoriatic arthritis are often socially isolated and have difficulty keeping up with work and daily activities."This survey provides new insights into the real-world impact of psoriatic arthritis," said NPF President Andrew Prince. "It's important for people with psoriatic arthritis to know they are not alone. There are a wide variety of resources available to help manage this complex disease." Participate in Surveys "
1.
enhancing survivors of brain tumors' quality of life.
2.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
3.
A protein with new anticancer activity has been identified
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Enzalutamide vs Abiraterone: Which is Better for mCSPC?
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
3.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
4.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
5.
Progressive Strategies in Oncology and Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Managing Common Side Effects During Cancer Treatment
5.
Clinical Insights in Oncology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation